Lilly Announces Positive Phase Ii Data On Investigational Medicine For Patients With Type 2 Diabetes




7th June 2009 -
Views: 1277
Eli Lilly and Company (NYSE: LLY) announced today new, positive Phase II study results of LY2189265, its investigational glucagon-like peptide 1 (GLP-1) analog administered subcutaneously once-weekly for the treatment of type 2 diabetes.
New Data From Boehringer Ingelheim's Ongoing Linagliptin Trial Programme Show Promising Safety And E




7th June 2009 -
Views: 1034
These phase II study results show a placebo-like safety and tolerability profile under these therapeutic conditions.
New Data Highlights Urgency In Bowel Cancer Screening




6th June 2009 -
Views: 1012
An analysis of bowel cancers by Biogrid Australia shows the current screening program, limited to three age groups, has found double the number of bowel cancers at the most curable stage, compared with cancers found after reporting of symptoms.
New Mental Health Laws And Community Visitors Scheme Welcomed




5th June 2009 -
Views: 1508
MHCSA Executive Director Geoff Harris stated: “This brings us another step closer to finally seeing a vast improvement to our mental health laws.
Support To Help Medical Research Happen




5th June 2009 -
Views: 1046
“Properly funded successful medical research is a building block support less privileged countries in our region and to attract and retain some of the brightest research minds in the country.